High Court Won't Mull Double Avandia Damages For Insurers

Law360, New York (April 15, 2013, 1:24 PM EDT) -- The U.S. Supreme Court refused Monday to review a decision allowing Humana Inc. to seek double damages from GlaxoSmithKline PLC in a putative class action over costs for Medicare patients allegedly harmed by diabetes drug Avandia, despite GSK’s argument that the remedy shouldn't be available to private insurers.

In a brief order, the high court denied without comment GSK’s petition for writ of certiorari, filed after a Third Circuit decision that revived a suit by Humana Medical Plan Inc. and Humana Insurance Co. against the drugmaker....
To view the full article, register now.